You cannot register anymore for this webinar

Wat kan Small Molecule Modelling u bieden?

How have computational protocols advanced in the last few years to make quantifiable impact in projects for small molecules in drug design?

Join us, for a 1-hour seminar and we will share a birds-eye view of how state-of-the-art science is being used routinely to alleviate challenging design questions and enabling ideation across different teams. This is with a view to achieving one critical goal: speeding up drug discovery cycles.

Join this webinar to learn about:
  • Modelling concepts
  • How modelling can be useful to small molecule drug design
  • A typical drug design casestudy using Schrodinger Modelling and how it benefits project progression
  • How you might want to be involved with Schrodinger for your projects

​About Schrödinger:
Schrödinger is a provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. The company is also applying its computational platform to a robust pipeline of drug discovery programs in collaboration with pharmaceutical companies and has co-founded leading biotech companies.
In addition, the company is using its platform to advance a pipeline of internal, wholly-owned drug discovery programs.

More information at www.schrodinger.com 
Presentations by:
Dr. Jas Bhachoo - Head of Scientific Education (Europe), Schrödinger

Dr. Daniel D. Robinson - Research Fellow

Moderator: 
Robin Chaudret - Senior Account Manager, Schrödinger

Duration
Presentations incl Q&A : 80 minutes

You can view this webinar from your computer, tablet or mobile phone.

About the presenters:

Dr. Jas Bhachoo: Since completing her studies at UCL, Jas has worked for a number of pharmaceutical companies in the UK, including Biofocus, where she was responsible for supporting the modelling efforts of numerous customers. She has held various roles in Schrodinger, including Senior Application Scientist where she assisted many researchers in their own efforts. More recently, Jas has focussed on sharing her experience with others by heading up Schrodinger's Education efforts in Europe and beyond.

Dr. Daniel Robinson: Daniel ontving zijn DPhil. in computationele chemie van de Universiteit van Oxford meer dan 20 jaar geleden. Sindsdien heeft hij voor verschillende bedrijven in de farmaceutische industrie gewerkt als modelbouwer en onderzoeksdirecteur. Hij is de auteur van verschillende wetenschappelijke artikelen over het gebruik van geavanceerde modelleringstechnieken voor het ontwerpen van samenstellingen in een reeks doel- en therapeutische gebieden, en bezit ook meer dan 20 patenten. 




Deel dit webinar